Physician profile
Michael Ray West
NPI 1437387396
$1,331.42
in general payments reported to CMS, 2019-2025
26 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $88.28 · 2021: $179 · 2022: $124 · 2023: $179 · 2024: $243 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $323.62 | 2020-2024 | Exalt Model D, Spyglass Discover |
| Ethicon US, LLC | $133.65 | 2019-2025 | Ethicon, Surgicel Nu-Knit |
| Davol INC. | $111.22 | 2022-2025 | Phasix Mesh |
| Shire North American Group INC | $96.70 | 2019 | |
| Tela Bio, INC. | $83.78 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $61.76 | 2019-2022 | |
| Lemaitre Vascular, INC. | $53.68 | 2024 | Artegraft Vascular Graft |
| Music City Medical Technologies, LLC | $47.25 | 2025 | |
| Innovation Technologies INC | $43.13 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $42.47 | 2024-2025 | |
| Integra Lifesciences Corporation | $37.88 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $36.64 | 2021-2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $30.15 | 2023 | Seglentis |
| Abbvie INC. | $28.45 | 2022-2025 | |
| Abbott Laboratories | $25.16 | 2024 | Esprit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20.97 | 2025 | Spy-Phi System |
| Medtronic, INC. | $18.99 | 2024 | Venaseal |
| Ossur Americas, INC. | $18.35 | 2025 | |
| Ekos Corporation | $17.77 | 2019 | |
| Endogastric Solutions, INC | $17.23 | 2023 | Esophyx |
| Tetraphase Pharmaceuticals, INC. | $15.26 | 2019 | |
| Innocoll Pharmaceuticals Limited | $15.20 | 2021 | |
| Melinta Therapeutics, LLC | $14.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.95 | 2023 | Spiriva Respimat, Stiolto Respimat |
| Braintree Laboratories, INC. | $12.09 | 2019 | |
| Baudax Bio INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.